TheStreet Network:
TheStreet
|
MainStreet
|
BankingMyWay
|
RealMoney
Home
About Stockpickr
|
How to Use
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
» Most-Viewed
» Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
» More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
4 Tech Stocks to Trade (or Not)
3 Big Stocks to Trade (or Not)
5 Stocks Setting Up to Break Out
5 Dividend Stocks That Want to Pay You More
5 Stocks Under $10 Set to Soar
» More Articles
My Stockpickr
Log In
|
Join for Free
Stock Game
Health Care: Drugs
NuPathe Inc. (PATH: NASDAQ)
$3.20
0.05 | 1.59%
05/17/13 - 04:00 PM ET
Quote
Ratings
Earnings
Fundamentals
Options Chain
Advanced Chart
Balance Sheet
Cash Flow
Income Statement
Growth Rates
Major Holders
Ratio Comparison
196.73K / 160.20K
Vol / Avg. Vol:
3.19 / 3.15
Open / Prev. Close:
3.10 - 3.20
Today's Range:
2.47 - 4.59
52 Wk Range:
-6.80%
Performance YTD:
No Rating
TheStreet Rating:
Find out if PATH is in Cramer's Portfolio
6-MONTH
CHART:
1-Day
|
5-Day
|
1-Month
|
3-Month
|
6-Month
|
1-Year
See Advanced Charting for PATH
Portfolios with
PATH
Portfolio Name
User Type
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Setting Up...
Contributor
Drugs Facing FDA Approval i...
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Stocks Under-$10 Moving Hig...
Contributor
Earnings Short Squeeze Play...
Contributor
Under-$10 Setting Up To Tra...
User
SMITTY
Contributor
Hot Biotech Trades for Seco...
Contributor
9 Health Care Stocks With 1...
View All
Latest
PATH
Headlines from TheStreet
4 Health Care Stocks Under $10 to Watch
04.16.13 | 03:04 pm
5 Under-$10 Stocks Primed to Trade Higher
12.20.12 | 12:12 pm
2013 FDA Drug Approval Decision Calendar
12.19.12 | 09:12 am
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
11.19.12 | 09:11 am
5 Biotech Stocks Under $5 Blasting Off
08.16.12 | 03:08 pm
NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript
08.14.12 | 02:08 pm
4 Stocks Under $5 Making Big Moves
07.17.12 | 12:07 pm
8 Stocks Under $10 Moving Higher
02.08.12 | 02:02 pm
11 Stocks to Watch: NuPathe, Universal Display
08.30.11 | 08:08 am
FDA Rejects NuPathe Migraine Patch
08.30.11 | 06:08 am
More Financial News for PATH
Press Releases for
PATH
Safeguard Scientifics Announces Second Quarter 2011 Financial Results
- Business Wire 07.27.11 | 06:07 am
See All Press Releases
Partner Headlines for
PATH
Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH
- NASDAQ 03.25.13 | 08:03 pm
Morning Market Losers
- Benzinga 09.26.12 | 09:09 am
7 Biotech Stocks Being Snapped Up By Insiders
- Seeking Alpha 03.16.12 | 05:03 pm
Why Antares Pharma Should Be On Your List For Long-Term Investment
- Seeking Alpha 03.16.12 | 08:03 am
NuPathe Announces Allowance of U.S. Patent Application for NP202
- Benzinga 02.29.12 | 04:02 pm
Nupathe's Zelrix Going Down A Path With Multiple Headwinds
- Seeking Alpha 12.09.11 | 09:12 am
5 Healthcare Stocks To Consider
- Seeking Alpha 09.01.11 | 08:09 am
Mid-Day Update: US Indexes Recover from Red; Consumer Confidence Data Still Weighs
- NASDAQ 08.30.11 | 04:08 pm
Stocks Recover from Consumer Confidence Data-Induced Slump; Commodities Trending Higher
- NASDAQ 08.30.11 | 04:08 pm
Morning Market Losers
- Benzinga 08.30.11 | 09:08 am
Refresh Stock Quote for NuPathe Inc. - PATH
Yahoo May Look to A...
Fine Vine: Old Dog,...
Biotech's Next Big ...
Home
About Stockpickr
How to Use
Join for FREE
STOCK GAME
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
Most-Viewed
Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
4 Tech Stocks to Trade (or Not)
3 Big Stocks to Trade (or Not)
5 Stocks Setting Up to Break Out
5 Dividend Stocks That Want to Pay You More
5 Stocks Under $10 Set to Soar
More Articles
My Stockpickr
My Stockpickr Profile
Inbox
Add New Portfolio
Edit My Profile